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Background: Low weight at birth is associated with obesity in later life. One hypothesis to explain such an association
is that genetic variants that increase the risk of obesity also reduce fetal weight. Recently, obesity in adults was found to
be associated with common variants of the fat mass and obesity-associated (FTO) gene. We examined the association
between FTO polymorphisms and birth weight in a singleton, full-term birth cohort of 494 newborn-mother pairs
without any complications.
Results: The risk alleles for obesity (“A” allele for the rs9939609 FTO variant and “G” allele for the rs9930506 FTO variant)
were associated with low weight at birth. The mean differences per risk allele were −79 g (95% CI: −129 to −30;
p = 0.002) for rs9939609 and −84 g (95% CI: −131 to −36; P < 0.001) for rs9930506. The level of association remained
statistically significant after adjustment for the maternal risk allele and for variables usually associated with birth weight
(−50 g, 95% CI: −99 to 0; p = 0.05 for rs9939609 and −48 g, 95% CI: −100 to 0; p = 0.05 for rs9930506). In the follow-up,
the allelic difference in weight was attenuated over time.
Conclusions: The FTO variants that confer a predisposition to obesity later in life appear to be associated with low
weight at birth. This finding favors the hypothesis of a common genetic denominator that predisposes to a low weight
at birth and obesity in adults.
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Low birth weight is associated with an increased preva-
lence of obesity and insulin resistance syndrome in adult
life, leading to an increased risk of type 2 diabetes,
hypertension, and cardiovascular disease [1-5]. Although
the mechanisms for this association are unknown, re-
searchers have proposed that it reflects fetal program-
ming in utero in response to maternal malnutrition
during pregnancy [2,6,7]. An alternative hypothesis [8] is
that genetic variants that increase the risk of disease also
reduce fetal weight.
Several independent, genome-wide, association studies
have recently identified a strong correlation between fat
mass and obesity-associated (FTO) polymorphisms and
obesity-related parameters (body mass index [BMI], total
body weight, and hip circumference) in adults and children
[9-11]. In childhood, although the known FTO risk alleles* Correspondence: olivierdescamps@hotmail.com
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unless otherwise stated.for obesity are associated with an increased BMI in the
postnatal period [12], they have no effect on birth weight.
This conclusion was drawn from large cohorts that were
not controlled for situations affecting birth weight, such as
gestational diabetes [13] or other gestational complications.
In the present study, we investigated the effect of two
common FTO polymorphisms on birth weight in a
singleton, full-term birth cohort without any maternal or
newborn complications.Methods
Study design
The mothers and their newborns were consecutively re-
cruited in the maternity ward during 2008 and 2009.
The nurses of the maternal unit collected blood samples
(cord blood) and recorded maternal (at entry) and new-
born (at delivery) anthropometric parameters. Birth weight
was measured to the nearest 1 g using a digital baby scale
Seca model 727 (Seca Belgium, Zwijndrecht), which in-
cludes a special damping system that allows for precise
weighing, even if the newborn is restless. Two trained
study nurses extracted data (parity, weight measured at
the first antenatal clinic, and gestational age estimated fromtral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Descamps et al. BMC Genetics  (2014) 15:145 Page 2 of 7early obstetric ultrasound) from the obstetric medical re-
cords and interviewed the mothers to obtain data on smok-
ing status and the genealogical tree (four generations).
The selection criteria of the mother–newborn pairs
were a Caucasian origin, eutocic delivery with cephalic
presentation between the beginning of the 37th week
and the end of the 41st week, singleton live birth, no
maternal use of alcohol or illicit substances, no gestational
complications, no diabetes, no congenital malformations
or perinatal problems, and an Apgar score of ≥ 7 during
the 1st minute and ≥ 9 by the 5th minute. Twenty-nine of
the original mother–newborn pairs who were recruited by
the nurses were excluded because of non-compliance with
one or more inclusion criteria, difficulty of genotyping, or
important missing data.
For infants participating in the follow-up program of
our hospital, body weight at 3, 6, 9, and 12 months was
collected from the pediatric medical records. For the
other children, we attempted to obtain data 1 year later by
phone for the most recent weight of the child. The study
protocol was approved by the Ethical Committee of the
Hospital of Jolimont (ECO22) and informed written con-
sent was obtained from all mothers before participation.
Genotyping
We examined two single nucleotide polymorphisms
(SNPs) of FTO (SNPs with the A risk allele for rs9939609
and the G allele for rs9930506) that were previously
shown to be strongly associated with obesity-related pa-
rameters in large European populations [9,14]. We were
particularly interested in the G allele for rs9930506 be-
cause it shows an even stronger association in Sardinian
and Italian populations [15,16] and because some infants
born in our hospital are partially of Italian descent (third
or fourth generation born in Belgium). Genotyping of
rs9930506 and rs9939609 was performed by Restriction
Fragment Length Polymorphism-Polymerase Chain Reac-
tion and Allele-Specific Oligonucleotide-Polymerase Chain
Reaction, respectively, with a success rate greater than
97.5%.
Estimation of sample size
Sample size was estimated for testing the primary hy-
pothesis that birth weight is different between newborns
with different genotypes (BMI was not used because
measurement of length is less reliable in newborns).
Based on the weights obtained in the first 100 newborns
(mean ± standard deviation: 3284 ± 347 g), the minimum
size for each group that was required to detect a 5% dif-
ference (a priori considered as relevant) was estimated
as 70, for a two-sided significance level of 0.05 and a
statistical power of 80% [17]. Based on the minor allele
(the “risk allele”) frequency obtained in the first 100 new-
borns (approximately 40% for both SNPs) and assumingHardy–Weinberg equilibrium, we set our target size to a
minimum of 447 mother–newborn pairs.
Statistical analysis
The analyses focused on birth weight. We examined as-
sociations separately for newborn and maternal geno-
types, and then mutually adjusted one for the other, as
well as for other non-genetic factors using multiple lin-
ear regression analysis (SPSS for Windows, version 8.0).
Adjustment for maternal genotype is important because
of the strong association between maternal and newborn
genotypes and our aim to establish whether any associa-
tions are primarily driven by newborn genetic variants
independent of maternal genotypes. Other non-genetic
factors that are known to affect birth weight were exam-
ined, including racial/ethnic origin (all subjects were
Caucasians but some were of Italian origin), sex, gesta-
tional age, parity, cigarette smoking, maternal BMI, and
weight gain during pregnancy. In all analyses, a per-
allele additive genetic model was examined.
Results
The characteristics of the newborns and their mothers
are shown in Table 1. The risk allele frequencies were
0.41 for rs9939609 and 0.43 for rs9930506, similar to
those reported in European cohorts (0.40 [9] and 0.44
[15]), in Flanders (0.41 for rs9939609 [18]), in Italians
(0.48 and 0.50 [16]), and in Sardinians (0.46 and 0.46
[15]) (Table 2). There was no evidence of departure from
the Hardy–Weinberg equilibrium (Table 2) or an as-
sociation with the number of Italian great-grandparents
(data not shown).
Association of newborn FTO and birth weight
For both SNPs, newborn homozygotes for the risk allele
weighed significantly less than newborn heterozygotes,
and weighed even less than the homozygotes for the
non-risk allele, with a clear gene-dose effect (Table 3).
The newborn risk alleles were associated with a lower
birth weight, with a mean difference per risk allele of −78 g
(95% confidence interval [CI]: −128 to −28; p = 0.002) for
rs9939609 and −83 g (95% CI: −131 to −36; p = 0.0006)
for rs9930506. The level of association did not change
when we adjusted for the maternal risk allele (Table 3).
Low birth weight was associated with maternal risk al-
leles in univariate analyses (Table 4), but this associ-
ation may have been attributed to the offspring’s FTO
gene because it was not more significant after adjust-
ment for newborn risk alleles.
Birth weight was correlated with sex (r = 0.15, p = 0.001),
gestational age (r = 0.33, p < 0,001), parity (r = −0.09,
p = 0.06), cigarette smoking (r = −0.26, p < 0.001), and ma-
ternal BMI (r = 0.17, p < 0.001), but not with Italian origin
of the grandparents (r = −0.06, p = 0.21). There was only a
Table 1 Characteristics of the newborns and their mothers
Characteristics Eligible data Values
Boys, N(%) 494 243(49%)
Weight, g 494 3251,8 ± 383,6
Lenght, cm 494 50,1 ± 2,0
Head circumference, cm 494 34,0 ± 1,4
BMI, kg/m2 494 13,0 ± 1,1
Ge stational age, weeks 494 39,1 ± 1,2
Mothers characteristics 494
Nullipara, N(%) 494 191(39%)
Smoking during pregnancy, N(%) 494 101(20%)
Age, years 494 28,7 ± 5,4
Height, cm 494 164,7 ± 6,1
Weight before delivery, kg 494 80,0 ± 14,8
BMI before delivery, kg/m2 494 29,45 ± 5,02
Weight at pregnancy diagnosis, kg* 486 67,2 ± 15,4
Calculated gain in pregnancy, kg** 486 12,8915,4
Weight after delivery, kg 450 73,0914,6
Calculated loss after delivery, kg* 450 -7,0 ± 2,2
Genealogical data 485
0 Italian Great-grandparents, N(%) 278(57%)
1-2 Italian Great-grandparents, N(%) 62(13%)
3-4 Italian Great-grandparents, N(%) 73(15%)
5-6 Italian Great-grandparents, N(%) 27(6%)
7-8 Italian Great-grandparents, N(%) 45(9%)
*self reported or unstandardized.
**calculated from self reported or unstandardized data on weight at
pregnancy diagnose.
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ing pregnancy (r = 0.07, p = 0.13). None of these factors
was significantly associated with the risk alleles. In particu-
lar, maternal BMI was not significantly associated with
newborn risk alleles, but it was significantly associated
with maternal risk alleles (p = 0.03 for maternal rs9930506
and p = 0.01 for the maternal rs9939609). Additionally,
maternal risk alleles were associated with newborn risk
alleles. Adjustment for factors that were significantly
(p < 0.05) associated with birth weight (sex, gestational
age, parity, current smoking during pregnancy, and
maternal BMI) only slightly decreased the strength of the
associations between newborn risk alleles and birth weight,
without affecting the statistical significance (Table 3).
These associations were not modified by inclusion of
weight gain during pregnancy.
Comparison of weight between the genotypes in childhood
There was no difference in weight between the geno-
types 3 months after birth in the subsamples of children
whose weight we could directly measure. There was alsono difference in weight between the genotypes 1 year
after birth in the 371 infants for whom we could obtain
information by phone (Table 5).
Discussion
In the present study, FTO variants that confer a predis-
position to obesity later in life appeared to be associated
with a low weight at birth. This association was not off-
set by an effect from the maternal genotype, as might
have been expected through an effect of the same vari-
ants on maternal energy intake [19]. This association
remained significant after adjustment for other possible
confounders. These weight differences were rapidly at-
tenuated after birth.
This is the first observation of such an inverse rela-
tionship between birth weight and FTO risk alleles for
obesity in full-term, singleton, healthy newborns. An as-
sociation between the more severe small-for-gestational
age phenotype and risk alleles of FTO (odds ratio for
SGA TA versus TT: 1.54; 95% CI: 1.07, 2.22], as well as
for other risk alleles (PTER and KCNJ11, two high-risk
alleles associated with obesity and diabetes in adults),
has been found by Morgan et al. [20]. Other studies have
also shown a similar link between the genetics of type 2
diabetes with low birth weight [21-25] or with small-for-
gestational age [26,27]. In contrast, the first study to
show an association between FTO and obesity [13], as
well as other studies [12,28-31] and a meta-analysis by
Kilpelainen et al. [32] (data from previous studies plus
analyses of 4 large European birth cohorts), found no in-
verse association between the FTO risk allele and birth
weight or evidence of a positive association by the
postnatal age of 2 weeks (12]. In the meta-analysis by
Kilpelainen et al. [32], among the 13 established risk alleles
for obesity in various genes, only FTO (rs1121980) and
MTCH2 (rs10838738) risk alleles were significantly
associated with a high birth weight (+11 ± 4 g/allele;
p = 0.013; n = 28,219) and low birth weight (−13 ± 5 g/
allele; p = 0.012; n = 23,680), respectively. None of these
associations remained significant after correction for mul-
tiple testing. Many factors may explain the discrepancy be-
tween these studies and our study. Different populations
are exposed to different environmental and genetic influ-
ences that may interact with FTO variants. Some of the
cohorts in the meta-analysis [32] were born a long time
ago (between 1918 and 1975), and most had a birth weight
ranging from 3361 to 3536 g, which is higher than that in
our cohort and in newborns of European origin (3357 g)
[33]. In some studies, data on birth weight were only self-
reported, or reported by the participants’ mothers, or
sometimes measured, but rounded to the nearest quarter
of a pound. These conditions decrease the power to detect
significant associations. Furthermore, most studies had no
information on gestational age, maternal DNA, or other
Table 2 Frequencies of FTO genotypes and alleles







Total 494 167(34%) 253(51%) 74(15%) 0.41
Maternal genotype
TT 167(32%) 95(57%) 72(28%)
TA 248(50%) 72(43%) 133(53%) 43(58%) 0.17
AA 79(16%) 48(19%) 31(42%)







Total 494 165(33%) 236(48%) 93(19%) 0.57
Maternal genotype
AA 155(31%) 93(56%) 62(26%) -
AG 249(50%) 72(44%) 124(53%) 53(57%) 0.60
GG 90(18%) - 50(21%) 40(43%)
*Chi-square test.
HWE: Hardy Weinberg equillibrium.
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the association. Finally, most previous studies did not
exclude non-singleton births, individuals born preterm
or post-term, gestational complications, or congenital
malformations/perinatal problems. These factors are known
to be associated with a greater prevalence of extreme birth
weight.
Although replication in independent samples is essen-
tial, our finding is compatible with the hypothesis (also
called the “fetal insulin hypothesis” [8]) that common
genes that are inherited by the fetus affect birth size and
predisposition to obesity, as well as its related complica-
tions in adult life [1-5]. How genetic variations in FTOTable 3 Associations of birth weight and newborn FTO genot
Exposure = Newborn
Newborn weight (g)
N Mean ± SD(g)
Genotypes
Homozygous for non rish allele 167 3314 ± 378
Heterozygous 253 3238 ± 386
Homozygous for risk allele 74 3157 ± 366





Adjusted for maternal allele -73(-130; -16)
Adjusted for maternal allele and other variables** -56(-107; -5)
Adjusted also for maternal BMI -50(-99; 0)
Adjusted also for Adjusted also for weight gain -48(-98: +2)
*Students T test.
**Adjusted for sex, gestational age, panty and current smoking during pregnancy.contribute to variation in fetal weight may not be a sim-
ple explanation. In adults, the FTO gene is thought to
contribute to weight gain by diminishing sensation of sa-
tiety and increasing energy and fat intake [34-36]. Such
an explanation is not satisfactory in fetuses where the
nutrients are completely provided by the maternal circu-
lation. An indirect effect of the maternal FTO gene via a
greater maternal energy intake is not conceivable be-
cause the maternal risk alleles were not independently
associated with a low birth weight in our study. In the
fetus, insulin is the main growth hormone and hyper-
or hypoinsulinemia can lead to macrosomia or growth
retardation, respectively [37,38]. Several studies haveypes or alleles
FTO SNP
FTO rs9930506 SNP
P value vs 1°group* N Mean ± SD(g) P value vs 1°group*
165 3326 ± 386
0,02 236 3236 ± 394 0,02
0,001 93 3161 ± 329 0,0006
er newborn risk-allele Mean difference (g) per newborn risk-allele
for rs9930506
P value Mean (g) (95% CI) P value
0,002 -83(-131; -36) 0,0006
0,09 -76(-132; -21) 0,007
0,03 -55(-105; -6) 0,03
0,05 -48(-100; 0) 0,05
0,06 -47(-95;+1) 0,06
Table 4 Associations of birth weight and maternal FTO genotypes and alleles
Exposure =Maternal FTO SNP
FTO rs9939609 SNP FTOrs9930506 SNP
Newborn weight (g) Newborn weight (g)
N Mean ± SD (g) P value vs 1°group* N Mean ± SD (g) P value vs 1°group*
Genotypes
Homozygous for non risk allele 155 3312 ± 383 155 3312 ± 383
Heterozygous 249 3227 ± 381 0,03 3227 ± 381 0,03
Homozygous for risk allele 90 3216 ± 383 0,06 3216 ± 383 0,06
Mean difference (g) per offspring risk-allele
for rs9939609
Mean difference (g) per offspring risk-allele
for rs9939609
Mean(95%CI) P value Mean(95%CI) P value
Various adjustments
Unadjusted -53(-102; -4) 0,03 -45(-94; 5) 0,08
adjusted for newborn allele -13(-70; 43) 0,65 -10(-66; 47) 0,20
adjusted for newborn allele and other variables** -10(-61; 41) 0,70 -15(-66; 36) 0,57
*Student’s T test.
**Adjusted for sex, gestational age, panty and current smoking during pregnancy.
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tion or sensitivity. In mice, induced expression of FTO
enhances the first phase of glucose-induced insulin secre-
tion in INS-1 cells of the pancreas [39]. In cultured
human myotubes, FTO overexpression alters insulin
signaling and increases de novo lipogenesis [40]. High-risk
alleles of FTO are also associated with lower cerebrocorti-
cal insulin sensitivity [41]. The effect of FTO variants
might also occur at the level of placenta where it is highly
expressed [42], similar to many other tissues [9]. In ani-
mals, placental mRNA abundance of FTO is positively
correlated with birth weight [43]. In humans, placental
FTO expression is associated with increased fetal weightTable 5 Change in weight of infants according to genotypes
FTO rs9939609 Newborns with TT genotype Newborns with
N mean (g) SD N mean (g) SD
At birth 167 3314 ± 378 253 3238 ± 386
3 months 31 5358 ± 404 60 5467 ± 627
6 months 25 7199 ± 494 54 7374 ± 635
9 months 31 9242 ± 491 55 9058 ± 779
1 year 127 10706 ± 753 190 10781 ± 917
FTO rs9930506 Newborns with AA genotype Newborns with
N mean (g) SD N mean (g) SD
At birth 165 3326 ± 386 236 3236 ± 394
3 months 30 5325 ± 386 56 5496 ± 648
6 months 25 7023 ± 358 50 7343 ± 685
9 months 30 9158 ± 517 51 9059 ± 787
1 year 126 10798 ± 761 173 10635 ± 893
*Student’s T test.and length, and with placental weight in infants from non-
primiparous women, as well as an increased fetal-to-
placental weight ratio in primiparous women. There are
also other intriguing findings regarding the possible effect
of FTO in maternal-fetal interactions. In the ALSPAC
cohort where maternal genotypes were available [44], a
maternal “risk-allele score” (combining 4 risk alleles for
obesity, including FTO rs9930609) was inversely associ-
ated with gestational weight gain in the first 18 weeks of
pregnancy (214.46 g/wk per allele) compared with three
other risk alleles for obesity. The maternal risk allele in
FTO showed the greatest trend of a negative association
with birth weight (−20.44 g; 95% CI: −42.65, 1.78; p = 0.07)TA genotype Newborns with AA genotype Statistic (P values)*
N mean (g) SD G2 vs G1 G3 vs G1
74 3157 ± 366 0,05 0,00
13 5271 ± 593 0,38 0,58
13 6989 ± 618 0,23 0,26
14 9058 ± 352 0,24 0,21
54 10738 ± 550 0,44 0,78
AG genotype Newborns with GG genotype Statistic (P values)
N mean (g) SD G2 vs G1 G3 vs G1
93 3161 ± 329 0,00 0,00
18 5283 ± 545 0,19 0,76
17 7164 ± 656 0,34 0,80
19 9197 ± 423 0,54 0,78
72 10937 ± 675 0,10 0,20
Descamps et al. BMC Genetics  (2014) 15:145 Page 6 of 7[44]. Fetal FTO may participate either in the control of
fetal weight gain or in the partitioning between maternal
storage, placental development, and fetal growth. Interac-
tions between maternal genetics and fetal metabolism or
reciprocally have been previously demonstrated for lipo-
protein metabolism [45,46]. However, how such interac-
tions occur and an explanation for the inverse relation
between the risk allele for obesity and low birth weight are
still speculative at this stage.
We recognize that our study has some limitations.
First, the associations observed in our study could be
false positives. A false positive association is frequently
caused by the confounding effect of population stratifi-
cation when ethnicity or geographic origin is associated
with the phenotype and genotype. We attempted to con-
trol for this type of bias by verifying and adjusting for
the origin (especially Italian origin). Our sample size is
small compared with the majority of genetic association
studies. This resulted in a lower power to detect any as-
sociations with a high level of statistical significance.
Calculation of statistical power using a mean difference
per allele of 50 g showed that we had a 44% power to
detect an association. Finally, birth weight is a simple
measure that does not discern between fat mass and
other components. Future studies need to investigate a
more precise measure of fat mass in newborns using
total body electric conductivity, dual energy x-ray ab-
sorptiometry, or air displacement plethysmography [47].Conclusions
In conclusion, the present study investigated 494 new-
borns with well-documented confounding factors that
affect birth weight. After exclusion of pathological situa-
tions affecting birth weight, the FTO risk allele for obes-
ity showed a significant, inverse association with birth
weight. This association remained significant after cor-
rection for confounding factors and maternal FTO vari-
ants. This observation is compatible with the notion that
genetic variants leading to obesity in later life may cause
lower weight in fetal life, and supports a role for FTO in
early growth.
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